Navigation Links
Gene therapy could expand stem cells' promise
Date:5/21/2009

Once placed into a patient's body, stem cells intended to treat or cure a disease could end up wreaking havoc simply because they are no longer under the control of the clinician.

But gene therapy has the potential to solve this problem, according to a perspective article from physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center published in a recent issue of the journal Cell Stem Cell. The paper details strategies for genetically modifying stem cells prior to transplantation in order to ensure their safety.

"Stem cell therapy offers enormous potential to treat and even cure serious diseases. But wayward stem cells can turn into a runaway train without a conductor. This is an issue that can be dealt with and we have the technology to do that in the form of gene therapy," says senior author Dr. Ronald G. Crystal, chief of the Division of Pulmonary and Critical Care Medicine at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and the Bruce Webster Professor of Internal Medicine and Professor of Genetic Medicine at Weill Cornell Medical College.

Stem cells have the capacity to differentiate into any of the different tissues making up the human body, thus holding the promise of treating or curing diseases such as multiple sclerosis or spinal-cord injury by replacing diseased cells with healthy cells.

But unlike other therapies such as chemotherapy, antibiotics or aspirin, stem cells have no expiration date, and that poses a real problem.

"Almost all therapeutics we use have a half life. They only last a certain amount of time," Dr. Crystal says. "Stem cells are the opposite. Once the future stem cell therapist does the therapy, stem cells have the innate potential to produce more cells."

The challenge takes on even more urgency with recent developments, including a federal administration now more open to exploring the potential of stem cells, the recent FDA appro
'/>"/>

Contact: John Rodgers
jdr2001@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2

Related biology news :

1. Breakthrough in radiotherapy promises targeted cancer treatment
2. From cars to cancer: UH professor employs auto industry tools for tumor therapy
3. Hebrew University researchers neutralize tumor growth in embryonic stem cell therapy
4. Moving gene therapy forward with mobile DNA
5. Simulated gene therapy
6. Early administration of antiretroviral therapy can improve survival
7. Stem cell therapy makes cloudy corneas clear, according to Pitt researchers
8. Gene therapy appears safe to regenerate gum tissue
9. Two-day symposium in Baltimore to tackle the promises and perils of proton radiotherapy
10. CSHL team develops mouse models of leukemia that predict response to chemotherapy
11. Taste, odor intervention improves cancer therapy, according to Virginia Tech, Wake Forest study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... to a whale entangled in fishing gear, scientists showed ... whale,s diving and swimming behavior. The monitoring revealed how ... depletes their energy as they drag gear for months ... , The scientists in this entanglement response suction-cupped a ... North Atlantic right whale called Eg 3911. The Dtag, ...
(Date:5/21/2013)... a new method for delivering molecules into single, ... surface. The technique could find applications in drug ... Bulk electroporation a technique used to deliver ... cell membrane that are caused by exposing them ... method of cell transfection. (Cell transfection is the ...
(Date:5/21/2013)... Think keeping in shape is an uphill battle? Try ... and prolonged weightlessness withers muscle and bone. , That,s ... will address with a new three-year, $1.2 million grant ... to exercise during multiyear exploratory missions. , "You could ... if you can,t get them to stick to it, ...
Breaking Biology News(10 mins):Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Single-cell transfection tool enables added control for biological studies 2Fueling fitness on the final frontier 2
... A novel bacterium that has been trapped more than three ... years, may hold clues as to what life forms might ... a team of scientists from Pennsylvania State University report finding ... , in the current issue of the International Journal ...
... -- Begins in Houston , , HOUSTON, June 10 ... of Houston Center for ... Technology , announce today their agreement for the ... for the U.S. Gulf Region. This Center will house all ...
... be anymore waiting in the dark at this campus bus ... group of engineering researchers at McMaster University has been installed ... The researchers are also hoping that the prototype will help ... shelter is located on the west side of University Avenue ...
Cached Biology News:A tiny frozen microbe may hold clues to extraterrestrial life 2University of Houston Site of Regional Center of Excellence 2Flexible solar strips light up campus bus shelter 2
(Date:5/22/2013)... 22, 2013 Cambridge Semantics was ... week’s “Data Demonstration Day” on Capitol Hill, hosted by The ... Google, Microsoft and others to showcase how innovative data management ... and Transparency Act (DATA Act). , Originally introduced in 2011 ... and Sen. Mark Warner (D-VA ), the ...
(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... pioneering the development of disease modifying therapeutics for ... today the completion of its Series B financing, ... shares and warrants that would represent approximately $2.8M ... investors and new investors supported the raise. ...
(Date:5/22/2013)... May 22, 2013  Superior Controls, Inc. has ... by Business NH Magazine.  For the past 22 ... that distinguish themselves with extraordinary business and civic ... receive this honor," said Rick Pierro ... any recognition, this award is a reflection of ...
(Date:5/22/2013)... Basel, Switzerland (PRWEB) May 22, 2013 ... solutions for industrial biotechnology, drug discovery, and life ... Genedata Selector ™ as its bioinformatics ... its production-relevant organisms. Genedata will provide AB Enzymes, ... manufacturers, with a hosted solution of Genedata Selector ...
Breaking Biology Technology:Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4
... BRISBANE, Australia and SEATTLE, Feb. 24 Implicit,Bioscience ... antibody IC14 from Eli Lilly and Company. Implicit ... to Lilly. Lilly will also,receive a royalty on ... "Implicit Bioscience brings substantial expertise and passion to ...
... Feb. 24 Nektar Therapeutics,(Nasdaq: NKTR ... fourth quarter and,year ended December 31, 2008. , ... year for Nektar," said Howard W. Robin,President and ... unique polymer,conjugation chemistry platform, we advanced numerous proprietary ...
... proteinTHOUSAND OAKS, Calif., Feb. 24 Bone Biologics, Inc. ... Aragen Bioscience, has completed development of a recombinant cell ... protein. Bone Biologics has been developing the protein as ... years of research in the lab performed by the ...
Cached Biology Technology:Implicit Licenses Clinical Stage Antibody Program From Lilly 2Implicit Licenses Clinical Stage Antibody Program From Lilly 3Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 2Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 3Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 4Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 5Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 6Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 7Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 8Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results 9Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences 2
... CyScribe GFX Purification Kit, 24 reactions. ... Cy3- and Cy5-labeled cDNA.Optimized reagents are ... and purification.Flexible and optimized protocols can ... with either Cy3- or Cy5-labeled nucleotides.Reliable ...
NORMAL DONOR DONKEY SERUM...
... 301 Power Supply, 1. 300 V, ... or constant current modes.Single-unit increments in ... reproducibility.Suitable for submarine, mini vertical, and ... as semidry and mini tank blotting ...
B3-1...
Biology Products: